Prasad Cooray

1.3k total citations
32 papers, 480 citations indexed

About

Prasad Cooray is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Prasad Cooray has authored 32 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 10 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Prasad Cooray's work include Colorectal Cancer Treatments and Studies (11 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Cancer Genomics and Diagnostics (9 papers). Prasad Cooray is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Cancer Genomics and Diagnostics (9 papers). Prasad Cooray collaborates with scholars based in Australia, United States and New Zealand. Prasad Cooray's co-authors include Shaun P. Jackson, Yuping Yuan, Simone M. Schoenwaelder, Hatem H. Salem, Christina A. Mitchell, Hatem H. Salem, Niall C. Tebbutt, Robert Stagg, Jennifer A. Shannon and Andrew Strickland and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemical Journal.

In The Last Decade

Prasad Cooray

31 papers receiving 476 citations

Peers

Countries citing papers authored by Prasad Cooray

Since Specialization

Citations

This map shows the geographic impact of Prasad Cooray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasad Cooray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasad Cooray more than expected).

Fields of papers citing papers by Prasad Cooray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasad Cooray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasad Cooray. The network helps show where Prasad Cooray may publish in the future.

Co-authorship network of co-authors of Prasad Cooray

This figure shows the co-authorship network connecting the top 25 collaborators of Prasad Cooray. A scholar is included among the top collaborators of Prasad Cooray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasad Cooray. Prasad Cooray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant Pembrolizumab Enables Successful Downstaging and Resection of Borderline Resectable MSI-H/dMMR Pancreatic Ductal Adenocarcinoma: A Case Report and Literature Review 2025 ·Journal of Gastrointestinal Cancer ·(unknown), Vijayaragavan Muralidharan, Shaun R. Brown, (unknown), (unknown), Prasad Cooray	0
2	Young-onset metastatic colorectal cancer: an opportunity and a vision for progress in cancer 2025 ·Medical Oncology ·Prasad Cooray, N.J. Cooper	2
3	Assessing real-world outcomes in metastatic colorectal cancer with KRAS^G12C mutation. 2020 ·Journal of Clinical Oncology ·Hui‐Li Wong, Wanyuan Cui, (unknown), Margaret Lee, Rachel Wong, Jeremy Shapiro, Jeanne Tie, Belinda Lee, Prasad Cooray, (unknown), Peter Gibbs, Benjamin Solomon, Jayesh Desai	1
4	Use of folfirinox chemotherapy in an Australasian population of pancreatic cancer 2018 ·Annals of Oncology ·(unknown), (unknown), (unknown), (unknown), Hui‐Li Wong, (unknown), Lara Lipton, Jeremy Shapiro, Prasad Cooray, (unknown), Matthew Burge, Rachel Wong, (unknown), Sue‐Anne McLachlan, Marion Harris, (unknown), Niall C. Tebbutt, Peter Gibbs, Belinda Lee	1
5	Circulating tumor DNA as a prognostic biomarker in early stage pancreatic cancer. 2018 ·Journal of Clinical Oncology ·Belinda Lee, Lara Lipton, Joshua D. Cohen, Jeanne Tie, Ammar A. Javed, Lu Li, David Goldstein, Prasad Cooray, Adnan Nagrial, Matthew Burge, Niall C. Tebbutt, Mehrdad Nikfarjam, Marion Harris, Anne Marie Lennon, Christopher L. Wolfgang, Cristian Tomasetti, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Peter Gibbs	5
6	YOSEMITE: A 3 arm double-blind randomized phase 2 study of gemcitabine, paclitaxel protein-bound particles for injectable suspension, and placebo (GAP) versus gemcitabine, paclitaxel protein-bound particles for injectable suspension and either 1 or 2 truncated courses of demcizumab (GAD) 2017 ·Annals of Oncology ·Antonio Cubillo Gracián, Andrew Dean, Andrés Muñoz, Manuel Hidalgo, Roberto Pazo-Cid, (unknown), T. Macarulla Mercadé, Lara Lipton, Marion Harris, (unknown), Joan Maurel, Carmen Guillén‐Ponce, N. C. Tebbutt, Prasad Cooray, Davendra Sohal, Mark M. Zalupski, Tatjana Kolevska, Robert Stagg, David Goldstein	22
7	Potential role of circulating tumor DNA (ctDNA) in the early diagnosis and post-operative management of localised pancreatic cancer. 2017 ·Journal of Clinical Oncology ·Belinda Lee, Joshua D. Cohen, Lara Lipton, Jeanne Tie, Ammar A. Javed, Lu Li, David Goldstein, Prasad Cooray, Adnan Nagrial, Matthew Burge, Niall C. Tebbutt, Mehrdad Nikfarjam, Marion Harris, (unknown), Christopher L. Wolfgang, Cristian Tomasetti, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Peter Gibbs	11
8	PD-023 Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy 2016 ·Annals of Oncology ·(unknown), Jens T. Siveke, Andrea Wang‐Gillam, Richard Hubner, Shubham Pant, Tomislav Dragovich, Vincent Chung, David Chang, Paul J. Ross, Prasad Cooray, Niall C. Tebbutt, (unknown), Bruce Belanger, Navreet Dhindsa, (unknown), (unknown), Daniel D. Von Hoff	3
9	Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial 2016 ·British Journal of Cancer ·(unknown), Niall C. Tebbutt, Timothy Price, (unknown), Nicole Wong, Anne-Sophie Veillard, (unknown), Katrin Marie Sjoquist, Nick Pavlakis, Andrew Strickland, Suresh Varma, Prasad Cooray, Rosemary Young, Craig Underhill, Jennifer A. Shannon, Vinod Ganju, Val Gebski	40
10	A phase II study of oxaliplatin/5FU/bevacizumab and concurrent pelvic radiation in patients with simultaneous primary and metastatic rectal cancer: The Chrome-B trial. 2016 ·Journal of Clinical Oncology ·Michael Michael, Julie Chu, Mathias Bressel, Joseph McKendrick, Prasad Cooray, Sarat Chander, Michael Jefford, Marijana Vanevski, Rachel Wong, Malcolm Steel, Trevor Leong, Alexander G. Heriot, Sam Ngan	1
11	Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent 2015 ·Clinical Colorectal Cancer ·(unknown), Hui‐Li Wong, Kathryn Field, Suzanne Kosmider, Jeanne Tie, Rachel Wong, Mark Tacey, Jeremy Shapiro, Louise Nott, Gary Richardson, Prasad Cooray, Ian T. Jones, Matthew Croxford, Peter Gibbs	9
12	Impact of primary tumor stage on survival following resection of metachronous liver and/or lung metastases in colorectal cancer. 2015 ·Journal of Clinical Oncology ·Hui‐Li Wong, Vishal Boolell, Suzanne Kosmider, Kathryn Field, Rachel Wong, Jeremy Shapiro, Prasad Cooray, Ian Hayes, Ian Faragher, Malcolm Steel, Peter Gibbs	1
13	Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer 2014 ·British Journal of Cancer ·Michael Michael, Sarat Chander, J McKendrick, John Mackay, Malcolm Steel, Rodney J. Hicks, Alexander G. Heriot, Trevor Leong, Prasad Cooray, Michael Jefford, John Zalcberg, Mathias Bressel, Bev McClure, Sam Ngan	5
14	A Phase II Trial of Integrated Preoperative Radiotherapy and Chemotherapy with Oxaliplatin 5-Fluorouracil and Folinic Acid in Patients with Locally Advanced Rectal Cancer: Trans-Tasman Radiation Oncology Group TROG 09.01 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Samuel Y. Ngan, Mathias Bressel, Bev McClure, Sarat Chander, J. McKendrick, Malcolm Steel, John Mackay, Prasad Cooray, Mukesh Kumar, A. H. Strickland, Alexander G. Heriot, Trevor Leong, (unknown)	1
15	A phase 1b study of the anticancer stem cell agent demcizumab (DEM) and gemcitabine (GEM) with or without paclitaxel protein bound particles (nab-paclitaxel) in patients with pancreatic cancer. 2014 ·Journal of Clinical Oncology ·Antonio Cubillo Gracián, Michael B. Jameson, Enrique Grande, Prasad Cooray, Francis Parnis, Peter Grimison, Mark Jeffery, Robert Stagg, Jakob Dupont, Niall C. Tebbutt	7
16	Abstract B78: A Phase Ib study of demcizumab (DEM, anti-DLL4) with gemcitabine (GEM) in patients with first line locally advanced or metastatic pancreatic cancer. 2013 ·Molecular Cancer Therapeutics ·Antonio Cubillo, Michael B. Jameson, Enrique Grande, Francis Parnis, Peter Grimison, Prasad Cooray, Mark Jeffery, Robert Stagg, Jakob Dupont, Niall C. Tebbutt	1
17	Final results of AGITG ATTAX3 study: Randomized phase II study of weekly docetaxel (T), cisplatin, and fluoropyrimidine (F) with or without panitumumab (P) in advanced esophagogastric (OG) cancer. 2013 ·Journal of Clinical Oncology ·Niall C. Tebbutt, Timothy Price, Katrin Marie Sjoquist, Anne-Sophie Veillard, (unknown), (unknown), Nicole Wong, Nick Pavlakis, Andrew Strickland, Suresh Varma, Prasad Cooray, Rosemary Young, Craig Underhill, Jennifer A. Shannon, Vinod Ganju, Val Gebski, (unknown)	4
18	Neoadjuvant therapy with nanoparticle albumin-bound (nab)-paclitaxel to enhance the resectability of locally advanced pancreatic cancer (LAPC). 2012 ·Journal of Clinical Oncology ·Prasad Cooray, Andrew Dean	3
19	Multiple periungual pyogenic granulomas following systemic 5‐fluorouracil 2006 ·Australasian Journal of Dermatology ·(unknown), Helen Saunders, Anand Murugasu, Prasad Cooray, Max Schwarz, Douglas L. Gin	13
20	Calpain Cleavage of Focal Adhesion Proteins Regulates the Cytoskeletal Attachment of Integrin αIIbβ3 (Platelet Glycoprotein IIb/IIIa) and the Cellular Retraction of Fibrin Clots 1997 ·Journal of Biological Chemistry ·Simone M. Schoenwaelder, Yuping Yuan, Prasad Cooray, Hatem H. Salem, Shaun P. Jackson	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact